VeriMomc12-13 pareth-15 hamilelikte güvenli mi?
CIR’s safety assessment of alkyl PEG/alkyl PEG‑ether ingredients (which explicitly covers C12‑13 pareth variants including C12‑13 Pareth‑15) concluded these ingredients are safe “when formulated to be non‑irritating” and reported negative reproductive/developmental study findings. ECHA registration/read‑across dossiers for C12‑13 alcohol ethoxylates report no reproductive hazards in available animal studies. Dermal cosmetic use therefore shows no evidence of reproductive hazard, but low measurable dermal exposure is plausible. (CIR 2012; PubMed summary; ECHA registration dossier).
Related ingredients
Frequently asked questions
- c12-13 pareth-15 hamilelikte güvenli mi?
- CIR’s safety assessment of alkyl PEG/alkyl PEG‑ether ingredients (which explicitly covers C12‑13 pareth variants including C12‑13 Pareth‑15) concluded these ingredients are safe “when formulated to be non‑irritating” and reported negative reproductive/developmental study findings. ECHA registration/read‑across dossiers for C12‑13 alcohol ethoxylates report no reproductive hazards in available animal studies. Dermal cosmetic use therefore shows no evidence of reproductive hazard, but low measurable dermal exposure is plausible. (CIR 2012; PubMed summary; ECHA registration dossier).
- c12-13 pareth-15 emzirirken güvenli mi?
- Same evidence base as pregnancy: no reproductive/developmental hazard identified in the CIR review and in ECHA dossiers. Dermal exposure from cosmetics is expected to be low but measurable; no data indicate mammary‑specific toxicity or contraindication for breastfeeding. (CIR 2012; ECHA dossier).
- c12-13 pareth-15 bebek cildi için güvenli mi?
- No infant‑specific reproductive or developmental toxicity data were found. The parent class has no identified reproductive hazard. Because infant skin has higher permeability/surface‑area‑to‑weight, exposure score is increased by +1 versus adults (adult e=1 → infant e=2). Note: this increases exposure only; hazard and mechanism remain unsupported by evidence. CIR recommends formulation to be non‑irritating. (CIR 2012; ECHA registration/read‑across).
- VeriMom c12-13 pareth-15 nasıl puanlıyor?
- VeriMom c12-13 pareth-15'yi EU CosIng, ECHA sınıflandırmaları ve PubMed çalışmalarına göre 93/100 (bilinen risk yok) olarak puanlar.
- Hamilelikte c12-13 pareth-15 yerine neler kullanılabilir?
- Benzer işlevli ve bilinen riski olmayan alternatifleri içeren listemize bakın.
Her etiketi 2 saniyede kontrol et
VeriMom'u ücretsiz indirin — herhangi bir ürünü tarayın ve hamilelik güvenlik puanını anında görün.
Tıbbi Sorumluluk Reddi
Bu bilgiler yalnızca eğitim amaçlıdır ve tıbbi tavsiye niteliği taşımaz. Güvenlik puanları kamuya açık verilere dayanmaktadır ve tüm riskleri yansıtmayabilir. Hamilelik veya emzirme döneminde herhangi bir ürünü kullanmadan önce her zaman sağlık uzmanınıza danışın.